EFIB24
The partnership of Biobased and Renewable Industries for Development and Growth in Europe (BRIDGE) is industries vision for building stronger more sustainable value chains, based on renewable raw materials, across Europe. It is the result extensive dialogue between a broad range of sectors, SMEs, Research Institutes and policy makers and will form part of the EU's new Research and Innovation programme, Horizon 2020.
Finding a route to a sustainable and competitive Europe has been high on the agenda in Brussels for some time. The Bioeconomy is well positioned to enable both these goals. Industrial biotechnology offers a route moving to a post petroleum society that creates not just sustainable products but also jobs, investment and a road back to prosperity for Europe. BRIDGE is the latest and largest collaboration between stakeholders making the vision of a sustainable and competitive Europe a reality.
Hear all about BRIDGE, the EU's €3.8 billion Public-Private Partnership, which will be discussed at length in a dedicated programme session as part of the European Forum for Industrial Biotechnology (EFIB) on 2 October at the Square, Brussels. Head of the Unit Biotechnology of DG Research & Innovation of the European Commission, Barend Verachtert, and speaker within EFIB's BRIDGE focus session sees “BRIDGE as a real challenge, characterised by many parties involved and many interests at stake but something that fits perfectly in the new European Horizon 2020 strategy to link research to innovation, and to focus on social challenges.”
The route to a sustainable and competitive Europe will be a challenging one, but this BRIDGE just made the route quicker and more efficient.
The full EFIB agenda will feature representatives from all the main stakeholders involved in industrial biotech business and policy including more representatives from the European Commission, SME's like Direvo and Proviron and large companies like P&G, DuPont and Clariant. To find out more and join the discussion, http://bit.ly/BRIDGEefib
Finding a route to a sustainable and competitive Europe has been high on the agenda in Brussels for some time. The Bioeconomy is well positioned to enable both these goals. Industrial biotechnology offers a route moving to a post petroleum society that creates not just sustainable products but also jobs, investment and a road back to prosperity for Europe. BRIDGE is the latest and largest collaboration between stakeholders making the vision of a sustainable and competitive Europe a reality.
Hear all about BRIDGE, the EU's €3.8 billion Public-Private Partnership, which will be discussed at length in a dedicated programme session as part of the European Forum for Industrial Biotechnology (EFIB) on 2 October at the Square, Brussels. Head of the Unit Biotechnology of DG Research & Innovation of the European Commission, Barend Verachtert, and speaker within EFIB's BRIDGE focus session sees “BRIDGE as a real challenge, characterised by many parties involved and many interests at stake but something that fits perfectly in the new European Horizon 2020 strategy to link research to innovation, and to focus on social challenges.”
The route to a sustainable and competitive Europe will be a challenging one, but this BRIDGE just made the route quicker and more efficient.
The full EFIB agenda will feature representatives from all the main stakeholders involved in industrial biotech business and policy including more representatives from the European Commission, SME's like Direvo and Proviron and large companies like P&G, DuPont and Clariant. To find out more and join the discussion, http://bit.ly/BRIDGEefib